Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck signs agreement to buy Acceleron Pharma for $11.5bn
Merck (MSD) has agreed to acquire all the outstanding shares of Acceleron Pharma for $11.5bn in cash.
Cardiovascular
-
01 Oct 2021
-
11 Feb 2021
AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability
Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.